Institut Paoli Calmettes Prostate Cancer Database
Recruiting
- Conditions
- Prostatic Neoplasms
- Registration Number
- NCT02869594
- Lead Sponsor
- Institut Paoli-Calmettes
- Brief Summary
Database of Institut Paoli-Calmettes patients diagnosed with prostate cancer
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Male
- Target Recruitment
- 10000
Inclusion Criteria
- Prostatic cancer
Exclusion Criteria
- Non applicable
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival of patients 10 years Overall survival of all patients who come in the center
- Secondary Outcome Measures
Name Time Method Collection of patients characteristics 10 years Collection of characteristics of patients treated at Institut Paoli Calmettes in order to set up prospective and retrospective studies
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie prostate cancer progression in the Institut Paoli-Calmettes database cohort?
How does data collection in NCT02869594 compare to standard-of-care treatment outcomes for localized vs metastatic prostate cancer?
Which biomarkers in the Paoli-Calmettes database correlate with response to androgen receptor pathway inhibitors in prostate cancer patients?
What adverse event profiles are observed in prostate cancer subtypes within the Institut Paoli-Calmettes observational database?
How do genomic alterations in the NCT02869594 cohort inform development of PARP inhibitor combinations for prostate cancer?
Trial Locations
- Locations (1)
Institut Paoli-Calmettes
🇫🇷Marseille, Bouches-du Rhône, France
Institut Paoli-Calmettes🇫🇷Marseille, Bouches-du Rhône, FranceDominique GENRE, MDContact+33 4 91 22 37 78drci.up@ipc.unicancer.fr